Investigation of phenylalanine ammonia lyase and processing alpha glucosidase I
苯丙氨酸解氨酶和加工α葡萄糖苷酶I的研究
基本信息
- 批准号:183895-2009
- 负责人:
- 金额:$ 2.26万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Discovery Grants Program - Individual
- 财政年份:2012
- 资助国家:加拿大
- 起止时间:2012-01-01 至 2013-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Enzymes are highly evolved proteins, exquisitely designed by nature for specific purposes. By fully understanding their mechanism of action and structure, we can exploit them as efficient biosynthetic tools, modulate biochemical pathways to obtain desired end-products, or develop inhibitor that can control activity-associated disease states. Two different enzymes from two yeasts will be investigated. Processing glucosidase I (Glu I) is critical to cell function in higher eukaryotes and has potential as a therapeutic target for anti-viral , anti-inflammatory, and anti-cancer drugs. Tyrosine/phenylalanine ammonia lyases (T/PAL) are enzymes with a wide range of specificty towards phenylalanine or tyrosine. The basis for this specificity is not understood. Activity with tyrosine is highly desirable, as the product, p-coumaric acid, has a high industrial demand. A better understanding of the mechanism and structure of Glu I and T/PAL is necessary to control or use these enzymes in health and commercial applications. In terms of basic research, both of these enzymes pose intriguing questions related to enzyme structure, function, and mechanism. This project will carry out the following: (1) site directed mutagenesis of potential key amino acid residues involved in substrate binding and catalysis , followed by kinetic and structural evaluation of the mutants; (2) examining the functional domain structure of the enzymes by cloning and expression of truncated gene products; (3) crystallographic studies to further our understanding of the enzyme structure/function. These experiments will clarify key aspects of the structure and mechanism of Glu I and T/PAL, and will allow us to exploit them through rational inhibitor synthesis (Glu I) and by designing enzymes to efficiently produce industrially important p-coumaric acid (T/PAL).
酶是高度进化的蛋白质,是大自然为特定目的而精心设计的。通过充分了解它们的作用机制和结构,我们可以将它们作为有效的生物合成工具来开发,调节生化途径以获得所需的最终产物,或者开发能够控制活动相关疾病状态的抑制剂。将对来自两种酵母的两种不同的酶进行研究。加工葡萄糖苷酶I(Glu I)是高等真核生物细胞功能的关键,有可能成为抗病毒、抗炎和抗癌药物的治疗靶点。酪氨酸/苯丙氨酸解氨酶(T/PAL)是一类对苯丙氨酸或酪氨酸具有广泛特异性的酶。这种特殊性的基础尚不清楚。酪氨酸的活性是非常可取的,因为产品p-香豆酸具有很高的工业需求。更好地了解Glu I和T/PAL的机制和结构对于控制或使用这些酶在健康和商业应用中是必要的。在基础研究方面,这两种酶都提出了与酶结构、功能和机制有关的有趣问题。本项目将进行以下工作:(1)对参与底物结合和催化的潜在关键氨基酸残基进行定点突变,然后对突变体进行动力学和结构评估;(2)通过克隆和表达截短的基因产物来检测酶的功能结构域;(3)结晶学研究,以加深我们对酶结构/功能的理解。这些实验将阐明Glu I和T/PAL的结构和机制的关键方面,并将使我们能够通过合理的抑制剂合成(Glu I)和通过设计酶来高效生产工业上重要的p-香豆酸(T/PAL)来开发它们。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scaman, Christine其他文献
Scaman, Christine的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scaman, Christine', 18)}}的其他基金
Investigation of phenylalanine ammonia lyase and processing alpha glucosidase I
苯丙氨酸解氨酶和加工α葡萄糖苷酶I的研究
- 批准号:
183895-2009 - 财政年份:2014
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Investigation of phenylalanine ammonia lyase and processing alpha glucosidase I
苯丙氨酸解氨酶和加工α葡萄糖苷酶I的研究
- 批准号:
183895-2009 - 财政年份:2011
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Investigation of phenylalanine ammonia lyase and processing alpha glucosidase I
苯丙氨酸解氨酶和加工α葡萄糖苷酶I的研究
- 批准号:
183895-2009 - 财政年份:2010
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Investigation of phenylalanine ammonia lyase and processing alpha glucosidase I
苯丙氨酸解氨酶和加工α葡萄糖苷酶I的研究
- 批准号:
183895-2009 - 财政年份:2009
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Egg lysozyme: Modification by mild glycosylation (for food use) and by site-directed mutagenesis (for non-food uses)
鸡蛋溶菌酶:通过轻度糖基化(用于食品用途)和定点诱变(用于非食品用途)进行修饰
- 批准号:
223965-1999 - 财政年份:2001
- 资助金额:
$ 2.26万 - 项目类别:
Strategic Projects - Group
Processing alpha glucosidase I: structure and mechanism
加工 α 葡萄糖苷酶 I:结构和机制
- 批准号:
183895-2000 - 财政年份:2001
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Processing alpha glucosidase I: structure and mechanism
加工 α 葡萄糖苷酶 I:结构和机制
- 批准号:
183895-2000 - 财政年份:2000
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Egg lysozyme: Modification by mild glycosylation (for food use) and by site-directed mutagenesis (for non-food uses)
鸡蛋溶菌酶:通过轻度糖基化(用于食品用途)和定点诱变(用于非食品用途)进行修饰
- 批准号:
223965-1999 - 财政年份:2000
- 资助金额:
$ 2.26万 - 项目类别:
Strategic Projects - Group
Kinetics, mechanism and sequence homology of a-glucosidase I from a yeast and plant source
酵母和植物来源的α-葡萄糖苷酶 I 的动力学、机制和序列同源性
- 批准号:
183895-1996 - 财政年份:1999
- 资助金额:
$ 2.26万 - 项目类别:
Discovery Grants Program - Individual
Egg lysozyme: Modification by mild glycosylation (for food use) and by site-directed mutagenesis (for non-food uses)
鸡蛋溶菌酶:通过轻度糖基化(用于食品用途)和定点诱变(用于非食品用途)进行修饰
- 批准号:
223965-1999 - 财政年份:1999
- 资助金额:
$ 2.26万 - 项目类别:
Strategic Projects - Group
相似国自然基金
L-苯丙氨酸通过lncRNA CHRF/miR-182-5p/BNIP3介导的线粒体自噬在人工甜味剂导致NAFLD中的机制研究
- 批准号:82370862
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Developing Synthetic Enzymes to Treat Inborn Errors of Metabolism
开发合成酶来治疗先天性代谢缺陷
- 批准号:
10281241 - 财政年份:2021
- 资助金额:
$ 2.26万 - 项目类别:
Developing Synthetic Enzymes to Treat Inborn Errors of Metabolism
开发合成酶来治疗先天性代谢缺陷
- 批准号:
10540317 - 财政年份:2021
- 资助金额:
$ 2.26万 - 项目类别:
Sarcopenia in cirrhosis is mediated by a hyperammonemic stress response
肝硬化中的肌肉减少症是由高氨血症应激反应介导的
- 批准号:
9976523 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Hepatocyte Transplantation for Liver Based Metabolic Disease
肝细胞移植治疗肝脏代谢疾病
- 批准号:
9762098 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
10451749 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Sarcopenia in cirrhosis is mediated by a hyperammonemic stress response
肝硬化中的肌肉减少症是由高氨血症应激反应介导的
- 批准号:
9751852 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
9977923 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别:
Tunable therapeutic modulation of the gut microbiome by engineered probiotics
通过工程益生菌对肠道微生物组进行可调节的治疗调节
- 批准号:
9761466 - 财政年份:2018
- 资助金额:
$ 2.26万 - 项目类别: